Study shows Covaxin safe, immunogenic in 2-18 age group: Bharat Biotech Ruchika Sharma31 Dec 2021 12:48 PM ISTHyderabad: Bharat Biotech International Limited (BBIL), has announced that BBV152 (COVAXIN), its whole-virion inactivated COVID-19 vaccine candidate,...
Biological E in talks with WHO over Corbevax approval, says Developer Ruchika Sharma31 Dec 2021 12:00 PM ISTHouston: Corbevax, a 'recombinant protein sub-unit' vaccine developed by Texas-based vaccine developers, was recently granted emergency approval by...
Is Omicron Variant Nature's Immunization Against Delta Variant? MD Bureau30 Dec 2021 10:35 PM ISTThe B.1.1.529 variant was first reported to WHO from South Africa on November 24, 2021. The Omicron variant diverges from the original SARS-CoV-2...
Covishield booster dose cannot be recommended without clinical trials: CDSCO panel Medical Dialogues Team16 Dec 2021 6:16 PM ISTAmid the emergence of the new Covid variant Omicron, the SII had sought approval to administer the booster dose of its Covishield vaccine on the basis...
Covid-19 vaccination associated with low Covid infection in cancer patients MD Editorial Team13 Dec 2021 9:00 AM ISTCancer patients are at a greater risk of severe COVID-19 infection, although it is uncertain if SARS-CoV-2 vaccine is useful for them. According to a...
Highly purified, safe vaccine: Bharat Biotech on Covaxin quality concerns Medical Dialogues Team6 Aug 2021 6:49 PM ISTNew Delhi: With multiple media reports raising questions about the quality of some batches of Bharat Biotech's Covaxin, the vaccine manufacturer has...
Covid-19: No recommendation made to mix 1st, 2nd doses of vaccines, says Govt Medical Dialogues Bureau5 Aug 2021 9:45 AM ISTThere is no specific recommendation from the World Health Organization presently on mix and match of vaccines, Minister of State for Health Bharati...
Covid-19: Covaxin effective against Delta plus variant, says ICMR study Medical Dialogues Bureau3 Aug 2021 9:30 AM IST"We have evaluated the IgG antibody titer and neutralizing potential of sera of COVID naive individuals full doses of BBV152 vaccine, COVID recovered...
Science behind "increasing gap between two Covishield vaccine doses to 12-16 weeks Medha Baranwal13 May 2021 11:45 AM ISTIndia: A government panel has suggested increasing the gap between two doses of the Covishield COVID-19 vaccine to 12-16 weeks. However, no such...
Give HBV booster vaccine at the earliest in thalassemic children, recommend Indian researchers Medha Baranwal3 April 2021 9:00 AM ISTNew Delhi: The administration of single booster dose of hepatitis B vaccine (HBV) after 5 years of primary immunization is sufficient for children...
Flu shot may reduce number and severity of COVID-19 cases: Study Hina Zahid24 March 2021 7:00 PM ISTPeople who received a flu shot last flu season were significantly less likely to test positive for a COVID-19 infection when the pandemic hit,...
Increase interval between 2 Covishield doses to 4-8 weeks: Centre to States, UTs Ruchika Sharma23 March 2021 3:08 PM ISTNew Delhi: In view of the emerging scientific evidence, the interval between two doses of a specific COVID-19 vaccine i.e. COVISHIELD, has been...
